David N Gill Insider Profile
4 Followers
David N Gill, Director at Telix Pharmaceuticals, holds 25.25K shares in Telix Pharmaceuticals (Ticker: TLPPF), holds 10.00K shares in Novanta (Ticker: NOVT). Most recently, David N Gill Bought ― shares of Telix Pharmaceuticals on Oct 26, 2026 for an estimated value of $29.88K.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-5.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that David N Gill holds in companies
Most Profitable Insider Trade
The most profitable trade made by David N Gill
David N Gill's Trading History
Telix Pharmaceuticals
Oct 26, 2026
Director
Informative Buy
29.88K
$222.68K
Novanta
―
Chief Operating Officer
―
$1.49M
List of latest transactions for each holding click on a transaction to see David N Gill's performance on stock
You May Also Like
David N Gill insider profile FAQ
What is the percentage of profitable transactions made by David N Gill?
The percentage of profitable transactions made by David N Gill is 50%.
What is the average return per transaction made by David N Gill?
The average return per transaction made by David N Gill is -5.10%.
What stocks does David N Gill hold?
David N Gill holds: TLPPF, NOVT stocks.
What was David N Gill’s latest transaction?
David N Gill latest transaction was an Informative Buy of $29.88K.
What was David N Gill's most profitable transaction?
David N Gill’s most profitable transaction was an Informative Buy of TLPPF stock on June 17, 2026. The return on the trade was 1.50%.
What is David N Gill's role in Telix Pharmaceuticals?
David N Gill's role in Telix Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.